#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Optic glioma Burkitt's lymphoma refractory Hyperphagia Erdheim-Chester disease Von Willebrand's disease Autoimmune disorder Short stature homeobox gene mutation Astrocytoma Acquired C1 inhibitor deficiency Chronic hepatitis B Follicle centre lymphoma follicular grade I II – III refractory Neuroendocrine tumour of the lung Epidermolysis bullosa Cold type haemolytic anaemia Autologous haematopoietic stem cell transplant More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Basic Information Mantle cell lymphoma stage II – Treatment Chondrosarcoma – Diagnostics Pulmonary fibrosis – Basic Information Castleman’s disease – Trials in Disease Ewing’s sarcoma recurrent KBG syndrome – Treatment Rhabdoid tumour – Life with Disease Glycogen storage disease type V Sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefazolin RLY-2608 Amantadine Hydrochloride Dl-Alpha-Tocopherol Mps-200 Febuxostat Hemihydrate Oms906 Mianserin Hydrochloride Dexamethasone Phosphate Nintedanib CIRTUVIVINT Triamcinolone Anv600 Fluoxetine Hydrochloride Clomifene Citrate Crovalimab Sulfamethizole Methyl Aminolevulinate Enfortumab Vedotin Ceralasertib More therapies…

    Learn about Your Condition

    Ovarian cancer stage IV Hepato-lenticular degeneration Immunodeficiency Colon cancer metastatic Primary biliary cholangitis Psychological trauma Juvenile absence epilepsy Thalassaemia alpha Skin wrinkling Endocarditis enterococcal MELAS syndrome Bacterial vaginosis Gouty arthritis Type 2 diabetes mellitus Loeys-Dietz syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Alitretinoin and Ciclosporin for Patients with Moderate to Very Severe Hand Eczema

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hand dermatitis
    Investigated Drugs:
    • Alitretinoin
    • Ciclosporin
    The Netherlands

  • Study on the Use of Adipose-Derived Stem Cells for Treating Hidradenitis Suppurativa in Patients with Draining Fistulas

    Not yet recruiting

    1 1
    Investigated Drugs:
    • Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells Expanded
    Spain

  • Study on Antibiotic Treatment with Metronidazole and Ciprofloxacin for Patients with Perianal Abscess After Surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anal abscess
    • Anal fistula
    Investigated Drugs:
    • Ciprofloxacin
    • Metronidazole
    The Netherlands

  • Study on Sulodexide for Preventing Recurrence of Blood Clots in Elderly Patients After First Episode of Deep Vein Thrombosis or Pulmonary Embolism

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Venous thrombosis
    • Pulmonary embolism
    Investigated Drugs:
    • Sulodexide
    Italy

  • Study on Pembrolizumab for Patients with High-Grade HPV-Related Vulvar and Cervical Lesions

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervical dysplasia
    • Vulvar dysplasia
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on Certolizumab for Women with Unexplained Recurrent Implantation Failure

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Implantation complication
    Investigated Drugs:
    • Certolizumab Pegol
    • Sodium Chloride
    France
Previous Page
1 … 862 863 864 865 866 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!